By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
The News GodThe News God
  • Politics
  • News
  • Business & Finance
  • Lifestyle & Health
  • Sports
  • Tech & Autos
  • Home and Garden
  • Other Categories
    • Travel
    • Education
    • Entertainment
    • Law
    • General
Reading: Roche Experiences a Setback in Alzheimer’s Therapy
Share
The News GodThe News God
  • Politics
  • News
  • Business & Finance
  • Lifestyle & Health
  • Sports
  • Tech & Autos
  • Home and Garden
  • Other Categories
Search
  • Politics
  • News
  • Business & Finance
  • Lifestyle & Health
  • Sports
  • Tech & Autos
  • Home and Garden
  • Other Categories
    • Travel
    • Education
    • Entertainment
    • Law
    • General
Follow US
  • Blog
  • Blog
  • Advertise
  • Advertise
The News God > Blog > News > Roche Experiences a Setback in Alzheimer’s Therapy
News

Roche Experiences a Setback in Alzheimer’s Therapy

Torffic Frimpong
Torffic Frimpong June 16, 2022
Updated 2022/06/16 at 11:02 AM
Share
3 Min Read
SHARE

In the wake of Roche’s recent failure with the cancer medication tiragolumab, the company announced on Thursday that its Alzheimer’s drug crenezumab was unable to halt or prevent cognitive decline in patients who possessed a particular genetic mutation that leads to the disease’s onset at an earlier age. This information was gleaned from research.

According to a statement released by the pharmaceutical company that makes Crenezumab, the drug’s co-primary objectives of assessing cognitive capacity and episodic memory function did not reveal statistically relevant therapeutic improvements.

Roche decided to conduct the Alzheimer’s Prevention Initiative (API) Autosomal Dominant Alzheimer’s Disease (ADAD) Colombia Trial to determine whether or not crenezumab can slow the progression of Alzheimer’s disease or even prevent it entirely in cognitively normal individuals who carry a particular genetic mutation.

The Basel-based business had previously encountered a significant obstacle with an unproven treatment for cancer that was being evaluated during the month before this one.

In the wake of Roche’s recent failure with the cancer medication tiragolumab, the company announced on Thursday that its Alzheimer’s drug crenezumab was unable to halt or prevent cognitive decline in patients who possessed a particular genetic mutation that leads to the disease’s onset at an earlier age. This information was gleaned from research.

According to a statement released by the pharmaceutical company that makes Crenezumab, the drug’s co-primary objectives of assessing cognitive capacity and episodic memory function did not reveal statistically relevant therapeutic improvements.

Roche decided to conduct the Alzheimer’s Prevention Initiative (API) Autosomal Dominant Alzheimer’s Disease (ADAD) Colombia Trial to determine whether or not crenezumab can slow the progression of Alzheimer’s disease or even prevent it entirely in cognitively normal individuals who carry a particular genetic mutation.

The Basel-based business had previously encountered a significant obstacle with an unproven treatment for cancer that was being evaluated during the month before this one.

An interim analysis of an ongoing clinical trial that was released in May found that the investigational medication TIRAGOLUMAB, which is manufactured by Roche, did not reduce the progression of disease in newly diagnosed patients with advanced non-small-cell lung cancer (NSCLC) in combination with Roche’s authorized PD-L1 immunotherapy Tecentriq. This information was gleaned from the ongoing trial.

You Might Also Like

Biden boosts US military deployments in Europe

Today’s Forecast: Thunderstorms and heavy rain will hit the south.

NYC grandmother was fatally struck by a vehicle that was evading police: report

 A federal judge has halted the implementation of a Louisiana abortion from having an impact.

A black bear dies in Tennessee when it broke into a heated car and became trapped.

Torffic Frimpong June 16, 2022
Share this Article
Facebook TwitterEmail Print
Share
Previous Article Chelsea Premier League fixtures 2022/2023:Key dates and Kick offtime. Chelsea Premier League fixtures 2022/2023:Key dates and Kick offtime.
Next Article Worker Compensation: How To Know If You Need To Hire A Lawyer Worker Compensation: How To Know If You Need To Hire A Lawyer
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stay Connected

235.3k Followers Like
69.1k Followers Follow
11.6k Followers Pin
56.4k Followers Follow
136k Subscribers Subscribe

Latest News

Edouard Mendy sends special words to Petr Cech after Chelsea's exit.
Edouard Mendy sends special words to Petr Cech after Chelsea’s exit.
Sports June 30, 2022
How to Choose the Right Concrete for Your Project
Home and Garden June 30, 2022
Hydro Excavation
5 great reasons to go for hydro excavation over other methods
Business & Finance June 30, 2022
Conveyancing Services: Everything You Need to Know About Residential Property Settlements
Business & Finance June 30, 2022

You Might also Like

News

Biden boosts US military deployments in Europe

June 29, 2022
News

Today’s Forecast: Thunderstorms and heavy rain will hit the south.

June 28, 2022
News

NYC grandmother was fatally struck by a vehicle that was evading police: report

June 28, 2022
News

 A federal judge has halted the implementation of a Louisiana abortion from having an impact.

June 27, 2022

© 2022 Thenewsgod. All Rights Reserved.

  • About
  • Contact Us
  • Terms of Use & Privacy Policy
  • Advertise
  • Disclaimer

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?